Certificate of Product Liability Insurance Provided upon request, contact your sales representative. Core processes that may be additional at the ISO 13485 sites include the following as they relate to the Mevopur medical line of products: Change control All changes concerning any Mevopur products are evaluated to determine whether there will be any impact on the product specification or the quality of the product. These standards are designed to mitigate potential health risks related to food products and or nutraceutical products from their packaging and/or any other material that may come into direct contact with it.

Cesa™ Anti-Block Slip LS Additives for low-temperature sealing layers in flexible polyolefin packaging FOOD PACKAGING IN A CHANGING MARKET In many food contact applications, flexible plastic packaging is replacing rigid packaging for varied reasons; it has lightweight characteristics, is easy to customize in any shape, and has a favorable carbon footprint. Avient makes no representations, guarantees, or warranties of any kind with respect to the information contained in this document about its accuracy, suitability for particular applications, or the results obtained or obtainable using the information. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.

As such, Avient Distribution does not manufacture any raw materials, participate in any material compounding nor mold any parts or final products. Are there any food allergens present in the plants? Yes, subject to commercially reasonable notice of request, prior approval and a non-disclosure agreement.

For this reason, avoid unnecessary contact with competitors. Conduct which would be “reasonable” and “lawful” for a company with less market power may have significant antitrust risk if done by a competitor with monopoly power. If a competitor’s ability to compete is harmed, it does not matter under the law whether the selling price or terms were reasonable or unreasonable.

Di Salvo is responsible for all aspects of the company’s capital structure, cash management, insurance and capital markets transactions, as well as Financial Planning and Analysis.

If any term in this Privacy Statement is unacceptable to you, please do not use the Website or provide any personal information. Please contact us as detailed below with any questions.   We will take all steps reasonably necessary to ensure that your personal information is treated securely and subject to appropriate safeguards in accordance with this Privacy Statement and applicable legislation.

High-permittivity lenses are beneficial in high-gain applications while keeping the size reasonable. You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product. This literature shall NOT operate as permission, recommendation, or inducement to practice any patented invention without permission of the patent owner. 1.844.4AVIENT www.avient.com

You are advised to consult any further disclosures we make on related subjects in our reports on Form 10-Q, 8-K and 10-K that we provide to the Each of such adjustments has not yet occurred, are out of the Company's control and/or cannot be reasonably predicted. For the same reasons, the Company is unable to address the probable significance of the unavailable information.

Oversee Regulatory Compliance. • Review and assess risks arising from the Company’s compensation policies and practices for its executive officers and employees and assess whether any such risks are reasonably likely to have a material adverse effect on the Company. • In consultation with appropriate officers of the Company, oversee (or provide for the oversight of) regulatory compliance with respect to compensation matters, including with respect to applicable tax laws. • Review and recommend to the Board for approval the frequency with which the Company will conduct Say on Pay Votes, taking into account the results of the most recent shareholder advisory vote on the frequency of Say on Pay Votes required by Section 14A of the Exchange Act, and review and approve the proposals regarding the Say on Pay Vote and the frequency of the Say on Pay Vote to be included in the Company’s proxy statement. Other Delegated Duties or Responsibilities. • Perform any other duties or responsibilities delegated to the Committee by the Board from time to time. Authority to Retain Experts • The Committee shall have appropriate resources and authority to discharge its responsibilities. • The Committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser to assist it in carrying out its responsibilities. • The Committee shall be directly responsible for the retention or appointment, compensation, and oversight of the work of any compensation consultant, independent legal counsel and other adviser retained by the Committee and for such adviser’s termination. • The Company must provide for appropriate funding, as determined by the Committee, for payment of reasonable compensation to a compensation consultant, independent legal counsel or any other adviser retained by the Committee.

Oversee Regulatory Compliance. • Review and assess risks arising from the Company’s compensation policies and practices for its executive officers and employees, and whether any such risks are reasonably likely to have a material adverse effect on the Company. • In consultation with appropriate officers of the Company, oversee (or provide for the oversight of) regulatory compliance with respect to compensation matters, including with respect to applicable tax laws. • Review and recommend to the Board for approval the frequency with which the Company will conduct Say on Pay Votes, taking into account the results of the most recent shareholder advisory vote on the frequency of Say on Pay Votes required by Section 14A of the Exchange Act, and review and approve the proposals regarding the Say on Pay Vote and the frequency of the Say on Pay Vote to be included in the Company's proxy statement. Other Delegated Duties or Responsibilities. • Perform any other duties or responsibilities delegated to the Committee by the Board from time to time. Authority to Retain Experts • The Committee shall have appropriate resources and authority to discharge its responsibilities. • The Committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser to assist it in carrying out its responsibilities. • The Committee shall be directly responsible for the retention or appointment, compensation and oversight of the work of any compensation consultant, independent legal counsel and other adviser retained by the Committee and for such adviser’s termination. • The Company must provide for appropriate funding, as determined by the Committee, for payment of reasonable compensation to a compensation consultant, independent legal counsel or any other adviser retained by the Committee. • The Committee shall have sole authority to retain and terminate any search firm to be used to assist the Committee in the identification of candidates for the position of Chief Executive Officer, including sole authority to approve the consultant’s fees and other retention terms.